e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Modulating the immune system in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Aspergillus fumigatus sensitization in COPD and smokers
Stéphanie Everaerts (Leuven, Belgium), Stephanie Everaerts, Erna Van Hoeyveld, Kristina Vermeersch, Lieven Dupont, Bart Vanaudenaerde, Xavier Bossuyt, Katrien Lagrou, Wim Janssens
Source:
International Congress 2015 – Modulating the immune system in COPD and asthma
Session:
Modulating the immune system in COPD and asthma
Session type:
Poster Discussion
Number:
3610
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stéphanie Everaerts (Leuven, Belgium), Stephanie Everaerts, Erna Van Hoeyveld, Kristina Vermeersch, Lieven Dupont, Bart Vanaudenaerde, Xavier Bossuyt, Katrien Lagrou, Wim Janssens. Aspergillus fumigatus sensitization in COPD and smokers. Eur Respir J 2015; 46: Suppl. 59, 3610
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The contribution of
Aspergillus fumigatus
to COPD exacerbations: a “sensitive” topic
Source: Eur Respir J, 56 (2) 2002223; 10.1183/13993003.02223-2020
Year: 2020
Colonisation with filamentous fungi and acute asthma exacerbations in children
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Aspergillus fumigatus during stable state and exacerbations of COPD
Source: Eur Respir J 2014; 43: 64-71
Year: 2004
LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Asthma
Year: 2013
LATE-BREAKING ABSTRACT: IgE sensitisation to A. fumigatus is associated with fixed airflow obstruction independent of atopic status
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
High burden of A. fumigatus among chronic respiratory diseases
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
The effect of cigarette smoke on key pathogens in COPD lung infection
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Sputum microbiota in Chinese adults with eosinophilic versus non-eosinophilic asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014
Lung development and the role of asthma and allergy
Source: Eur Respir Mon 2012; 56: 82-96
Year: 2012
Clinical phenotypes in asthmatic population with severe asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Outcomes of immunotherapy of patients with COPD
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept